Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of The American Academy of Dermatology Année : 2021

Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients

Patricia Senet
  • Fonction : Auteur
Olivier Fain
François Chasset
  • Fonction : Auteur

Dates et versions

hal-04027476 , version 1 (13-03-2023)

Identifiants

Citer

Raphael Aitmehdi, Laurent Arnaud, Camille Francès, Patricia Senet, Jean-Benoît Monfort, et al.. Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients. Journal of The American Academy of Dermatology, 2021, 84 (4), pp.1171-1174. ⟨10.1016/j.jaad.2020.11.014⟩. ⟨hal-04027476⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More